http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3373936-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
filingDate | 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e605db73366cea07df847b0cadd8c11e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a45af40da0cb20d6b2a154f2174b8968 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c83318354c6014b8fc5f317ab588e70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44007c0302de7e42cd93a1364816a8c |
publicationDate | 2018-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-3373936-A1 |
titleOfInvention | 4-(4-cyano-2-thioaryl)dihydropyrimidinones for treating chronic wounds |
abstract | The invention relates to 4-(4-Cyano-2-thioaryl)dihydropyrimidinones of the formula (I) known from WO 2009/080199(A1) for use in a method for the treatment and/or recurrence rate reduction of a chronic wound selected from different types of ulcers and a chronic wound associated with Behçet's disease wherein the compound of the formula (I) is administered orally and wherein the treatment and/or reduction of recurrence rate of the chronic wound causes one or more of the effects selected from an increased wound closure rate, a reduced wound size, a shorter time to wound closure, an increase of the reepithelialisation of the chronic wound, an increase of the deposition of extracellular matrix such as collagen in the chronic wound, and a reduction of pain related to the chronic wound. The invention further relates to compounds of the formula (I) for use in a method for the treatment of neutrophilic dermatoses or for use in a method for the treatment of autoimmune blistering dermatoses. |
priorityDate | 2015-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 814.